Heuking advises UK-based Vidac Pharma Holding PLC on its listing on Hamburg Stock Exchange’s Regulated Unofficial Market
March, 2023 - Germany
Cologne-based Heuking capital markets experts Dr. Mirko Sickinger, LL.M. and Sven Radke, LL.M. adised Vidac Pharma Holding PLC on its listing on Hamburg Stock Exchange’s High Risk Market segment.
Established in 2021, London-based Vidac Pharma Holding PLC is the holding company of Vidac Pharma LTD, founded in 2012 and headquartered in Israel. Vidac Pharma LTD is a clinical stage biopharmaceutical company dedicated to discovering and developing first-in-class medicines to help people suffering from a range of oncologic and dermatologic diseases.
Counsel to Vidac Pharma Holding PLC
Heuking Kühn Lüer Wojtek:
Dr. Mirko Sickinger, LL.M. (Lead),
